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Abstract: The electrochemical redox behavior of three trinuclear Ni(II) complexes [Ni3(abb)3(H2O)3
(µ-ttc)](ClO4)3 (1), [Ni3(tebb)3(H2O)3(µ-ttc)](ClO4)3·H2O (2), and [Ni3(pmdien)3(µ-ttc)](ClO4)3 (3),
where abb = 1-(1H-benzimidazol-2-yl)-N-(1H-benzimidazol-2-ylmethyl)methan-amine, ttcH3 =
trithiocyanuric acid, tebb = 2-[2-[2-(1H-benzimidazol-2-yl)ethylsulfanyl]ethyl]-1H-benzimidazole,
and pmdien = N,N,N′,N”,N”-pentamethyldiethylenetriamine is reported. Cyclic voltammetry
(CV) was applied for the study of the electrochemical behavior of these compounds. The results
confirmed the presence of ttc and nickel in oxidation state +2 in the synthesized complexes.
Moreover, the antibacterial properties and cytotoxic activity of complex 3 was investigated. All the
complexes show antibacterial activity against Staphylococcus aureus and Escherichia coli to different
extents. The cytotoxic activity of complex 3 and ttcNa3 were studied on G-361, HOS, K-562, and MCF7
cancer cell lines. It was found out that complex 3 possesses the cytotoxic activity against the tested
cell lines, whereas ttcNa3 did not show any cytotoxic activity.
Keywords: nickel complexes; trithiocyanuric acid; trimercaptotriazine; cyclic voltammetry
1. Introduction
Trithiocyanuric acid (trimercaptotriazine acid, ttc) is an organic heterocyclic compound that
consists of triazine ring and three sulfurs on carbon atoms. It can be either in thiol or thione form
according to the conditions. As a trisodium salt, it is used for precipitation of heavy metals from
wastewaters [1–5]. In the last three years, many papers on the utility of the acid appeared but the
compound was mainly utilized for the preparation of nanostructures or nanocomposites with carbon
nanomaterials [6–8]. Six viable donor atoms of ttc can be involved in the coordination to metal
ions. Besides the precipitate formation, many compounds were prepared in crystalline form [9,10].
Metal ions can be coordinated by sulfur or nitrogen atom of ttc only to form mononuclear to trinuclear
complexes; however, even more complicated compounds were prepared, such as hexanuclear gold(I)
cluster [11] and sandwich-like structure of hexanuclear copper(I) complex [12]. Many of the important
properties of the transition metals' complexes including their shape, color, magnetism, and reactivity
depend on the electron occupancy of the metals'd-orbitals [13,14]. There are several parameters that
can affect the geometrical structure of a transition metal's complex, particularly the number of d
electrons of the metal. Some structures of mononuclear nickel(II) complexes have already been solved.
The coordination sphere of nickel central atoms was completed by tridentate [15,16] or tetradentate
nitrogen ligands [17–19]. Considering the properties of amine ligands, the coordination number of
nickel can be either five or six with nitrogen only or N, S chelating mode of ttc. A later study on
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coordination properties of nickel ttc shows the possibility of preparing even heptanuclear cluster
[Ni7(pmdien)6(H2O)2(µ-ttc)3](ClO4)5·3H2O [20].
Known platinum containing drugs including cisplatin [21] and oxaliplatin [22] show anti-cancer
properties; however, platinum-based therapy lacks the selectivity for cancer cells and cause undesirable
side effects such as nerve damage, hair loss, and nausea. Furthermore, platinum-based therapy is
not effective against many common types of cancer. In addition, chemotherapy failure might be
attributed to tumor resistance to oxaliplatin [23,24]. Therefore, it has been highly important to find
potential substitutes for the platin drugs. In our previous work, we reported synthesis and study on
mixed ligand complexes with Zn2+, Fe2+, and Mn2+ involving ttc ions [25]. It was found that iron and
manganese ions show high cytotoxicity, whereas mononuclear zinc and nickel ones were inactive.
The synthesis and structural characterization of three trinuclear Ni(II) complexes namely
[Ni3(abb)3(H2O)3(µ-ttc)](ClO4)3 (1), [Ni3(tebb)3(H2O)3(µ-ttc)](ClO4)3·H2O (2), and [Ni3(pmdien)3(µ-ttc)]
(ClO4)3 (3), were previously reported [26–28] (Scheme 1). Here, we report on the electrochemical behavior
of complexes that have not been studied yet. In our previous papers, we studied antibacterial and
cytotoxic activities of complexes 1 and 2, but such data were missing for complex 3. It was our aim to
complete the study on complex 3, which contains methyl groups on pmdien ligand, and thus, hydrogen
bonds are present in its structure [26].
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As shown in Figure 1A, there is a cathodic peak around −1.0 to −1.1 V, which appeared in all the 
recorded CVs. It is because of the reduction of the solvent component. In Figure 1Ac, the CV of ttc 
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Scheme 1. Trinuclear nickel(II) cations depicted with Mercury software [29]. Green stands for
nickel, violet for nitrogen, yellow for sulfur, and red for oxygen atoms. Perchlorate anions and
hydrogen atoms were omitted for clarity. The structural data of the complexes can be found in [26–28].
The ligands abb = 1-(1H-benzimidazol-2-yl)-N-(1H-benzimidazol-2-ylmethyl)methan-amine, tebb =
2-[2-[2-(1H-benzimidazol-2-yl)ethylsulfanyl]ethyl]-1H-benzimidazole, and pmdien = N,N,N′,N”,N”-
pentamethyldiethylenetriamine are depicted under corresponding complexes.
2. Results and Discussion
2.1. Electrochemical Study
As shown in Figure 1A, there is a cathodic peak around −1.0 to −1.1 V, which appeared in all
the recorded CVs. It is becaus of the reduction of the solvent component. In Figur 1A c, the CV
of ttc shows three oxidation peaks at Epa1; −0.81 V, Epa2; −0.65 V, and Epa3; −0.40 V, respectively.
T ere is also a reduction pe k in cathodic sc n at Epc2; −0.68 V. The electrochemical behav or of
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ttc is a complex process because of its structure. Its redox reaction might follow two main paths.
First, the second oxidation and its corresponding reduction at Epa2; −0.65 V and Epc2; −0.68 V could be
due to the reversible oxidation of tricyanic acid (Scheme 2A b), which can be formed by hydrolysis of
ttc (Scheme 2A a). However, ttc itself can be irreversibly oxidized to s-triazine-2,4,6-trion (Scheme 2A
c). This irreversible oxidation takes place at more positive potential (oxidation at Epa3; −0.40 V).
In addition, the second mechanism corresponds to the oxidation peak at −0.81 V that may be due to
the oxidation of ttc followed by the polymerization of the product (Scheme 2B). A similar mechanism
has been previously reported for the melamine, which has structural similarities with ttc [30].
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Furthermore, in Figure 1A b, an oxidation peak is observed at −0.22 V, which can be attributed to
the oxidation of Ni+2 → Ni+3 . The CVs of the studied complexes are shown in Figure 1B–D. In the
case of complex 3, the oxidation peaks can be observed at the same potentials as ttc. Thus, the presence
of ttc in complex 3 is confirmed. The ligand pmdien is an aliphatic one and no other redox exchanges
can be expected. Similarly, the oxidation peaks at the same potentials as ttc can be observed in the CV
of complex 2, indicating the existence of ttc in the complex. It is very probable that benzimidazole rings
do not influence the electrochemical behavior of the complex due to the conformation of tebb ligands
showing facial-like coordination with two nitrogen atoms of benzimidazoles in plane of octahedron
and sulfur atom of benzimidazole in apical position causing twist of benzimidazole rings as reported
before [28]. It is also possible that aliphatic chains in ligands do not allow for a simple exchange of
electrons. However, the CV of complex 1 differs to the other complexes as only one reversible couple can
be observed about −0.2 V, which might be due to the redox of the nickel. This Ni(II)–Ni(III) exchange
might be promoted by planarity of ligand abb as well as by a smaller distance of benzimidazole
moieties. Even though the oxidation potential of Ni2+/Ni3+ couple is highly affected by the composition
of the complex, it was reported to vary from −0.24 to −0.42 V in complexes with thiolato groups [31,32],
which is in accordance with the obtained results.
2.2. Antibacterial Activity
The growth curves showing on antibacterial activities are depicted in Figure 2.
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As can be seen from the curves, there are only low activities on Gram-positive bacteria and the
highest concentration used (0.5 mg·mL−1) was only able to decrease the growth of S. aureus. On the
other hand, much higher activity was observed on E. coli, where the highest concentration of complex
inhibits bacteria growth. Nickel chloride as well as pmdien have no antibacterial activities. When we
compare these findings with antibacterial activity of complex 1 [27], it can be concluded that the ligand
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abb and especially its nickel complex have much better activities against S. aureus and comparable
antibacterial activity on E. coli. One should expect higher antibacterial activity in compounds containing
sulfur in the structure, but conformation, i.e., planarity vs. nonplanarity of ligands and possible π–π
interactions play a very important role in binding to active sites [33,34].
There are various parameters, which could influence the biological properties of a complex.
The sphere of complexes 1 and 2 is completed by bisbenzimidazoles. The interaction with DNA is
probably based on the intercalation due to the existence of aromatic rings for π–π interaction. There
is also a question of orientation of the rings as abb in complex 1 is nearly planar in contrary to the
tebb ligand in complex 2, where coordination is facial-like and there is a longer Ni-S bond distance.
Furthermore, ligand abb has one more nitrogen for possible hydrogen bonding with DNA. In contrary,
complex 3 has a pmdien ligand coordinated to central atoms. The hydrogens of methyl groups can be
used for hydrogen bonding in this case. The helical structure of complex 3, proved by X-ray study,
is predetermined for strong interaction with DNA. The higher antibacterial activity of complex 1 might
be also due to the oxidation of the central atom which occurs around −0.2 V; however, it was not
observed in the case of complex 3 in the scanned potential window.
2.3. Study the Cytotoxic Activity
The cytotoxic activity of complex 3 and ttcNa3 were studied on G-361 (human malignant
melanoma), HOS (human osteogenic sarcoma), K-562 (human chronic myelogenous leukaemia),
and MCF-7 (human breast adenocarcinoma) cancer cell lines. Salt ttcNa3 shows no activity against
the tested lines. Complex 3 shows cytotoxic activity against all the tested cell lines with the following
results: on G-361 the average IC50 value is equal to 31.6 µM, HOS with IC50 = 15.5 µM, K-562 with IC50
= 45.9 µM, and MCF7 with IC50 = 25.1 µM. This is an interesting result, even though, in comparison
with IC50 of cisplatin (2.9, 3.0, 4.7, and 10.9 µM) and oxaliplatin (7.1, 6.8, 8.8, and 18.2 µM), complex 3
is less effective, but comparable activity is shown on the MCF7 cell line. It is also of interest that the
complex [Cu3(pmdien)3(µ-ttc)](ClO4)3 of the same composition as the title complex, except for central
atoms, shows no cytotoxic activity [35,36]. The activity of complex 3 can also be explained by its better
solubility and finally by its helical structure.
3. Materials and Methods
The electrochemical measurements were carried using the electrochemical analyzer 663 VA stand
(Metrohm, Switzerland), where a hanging mercury drop (HMDE) was used as the working electrode,
a Pt wire served as the counter electrode, and an Ag/AgCl (1 M, KCl) as the reference electrode.
The electrochemical measurements were performed in a buffer composed of 1.750 µL H2O + 100 µL of
the mixture (1 M HCl + 3 M NH3). The desired volume of the sample was added to the solution. The
CV was applied for the study of the electrochemical behavior of the compounds with parameters as
follows: start potential −1.5 V, final potential 0.0 V, scan rate 50 mV·s−1. Antibacterial properties of
complex 3 were studied on S. aureus (NCTC 8511), E. coli (NCTC 13216), and MRSA obtained from the
Czech Collection of Microorganisms, Faculty of Science, Masaryk University, Brno, Czech Republic.
The antimicrobial effect was determined on the instrument Multiskan EX (Thermo Fisher Scientific,
Dreieich, Germany) by absorbance measurement at 600 nm. The cytotoxic activity of complex 3 and
ttcNa3 was established in vitro against four cell lines G-361, HOS, K-562, and MCF-7. The cancer cells
were kept in 75 mL tissue culture flasks (TPP) and Dulbecco's modified Eagle's cell culture medium
(DMEM) composed of 1 mg·mL−1 glucose, 4 mM glutamine, 100 µg·mL−1 streptomycin, 10% bovine
serum, 100 IU·mL−1 penicillin, and 3.7 mg·mL−1 Na2CO3. Approximately 1.25 × 10−5 cells·mL−1 were
poured into 96-well plates (Nunc, 80 µL per well). After incubation (12 h, 37 ◦C, 5% CO2), the tested
compounds, in six-fold dilutions, were added (20 µL per well). After incubation of cells (72 h) with
the tested compounds, the cells were incubated with calcein AM and the fluorescence of the live cells
was measured at 485 nm excitation and 538 nm emission on Fluoroscan Ascent (Labsystems, Vantaa,
Finland). IC50 values, the drug concentrations lethal to 50% of the cancer cells, were guessed.
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4. Conclusions
The redox reaction of the trinuclear nickel complexes was studied. Mainly, the observed redox
peaks are attributed to the presence of ttc and nickel(II) ion in the complexes. However, the redox
peaks are affected by the spatial structure and composition of the studied complexes. Furthermore, the
antibacterial study of the complexes revealed that the presence of an appropriate ligand can induce the
antibacterial properties to the trinuclear nickel(II) complex. Interestingly, complex 3 shows a cytotoxicity
effect on the tested cell lines, while ttcNa3 did not show any cytotoxicity activity. As explained, the type
of the central atom as well as the solubility and the helical structure affect the cytotoxic activity of the
complex. It must be mentioned that the potential toxicity of ttc containing complexes can be overcome
by drug carriers like liposomes [37] or apoferritin [38]. Anyway, further study (in vivo) is necessary to
prepare and characterize compounds with potential use in medicinal practice.
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Eckschlager, T.; Stiborová, M.; et al. Folic acid-mediated re-shuttling of ferritin receptor specificity
towards a selective delivery of highly cytotoxic nickel(II) coordination compounds. Int. J. Boil. Macromol.
2019, 126, 1099–1111. [CrossRef]
29. Macrae, C.; Bruno, I.J.; Chisholm, J.A.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Rodriguez-Monge, L.;
Taylor, R.; Van De Streek, J.; Wood, P.A. Mercury CSD 2.0–New features for the visualization and investigation
of crystal structures. J. Appl. Crystallogr. 2008, 41, 466–470. [CrossRef]
30. Guan-Ping, J.; Bo, Y.; Zhen-Xin, C.; Xiu-Yu, C.; Ming, Z.; Chang, Z. Electrochemical behaviors and
determination of melamine in neutral and acid aqueous media. J. Solid State Electrochem. 2010, 15, 2653–2659.
[CrossRef]
Materials 2020, 13, 1782 8 of 8
31. Krüger, H.-J.; Peng, G.; Holm, R.H. Low-potential nickel(III,II) complexes: New systems based on tetradentate
amidate-thiolate ligands and the influence of ligand structure on potentials in relation to the nickel site in
[NiFe]-hydrogenases. Inorg. Chem. 1991, 30, 734–742. [CrossRef]
32. Singh, J.; Hundal, G.; Gupta, R. Studies on Nickel(II) Complexes with Amide-Based Ligands: Syntheses,
Structures, Electrochemistry and Oxidation Chemistry. Eur. J. Inorg. Chem. 2008, 2008, 2052–2063. [CrossRef]
33. Anacona, J.R.; Mago, K.; Camus, J. Antibacterial activity of transition metal complexes with a tridentate NNO
amoxicillin derived Schiff base. Synthesis and characterization. Appl. Organomet. Chem. 2018, 32, e4374.
[CrossRef]
34. Santos, A.F.; Brotto, D.F.; Favarin, L.R.; Cabeza, N.A.; Andrade, G.R.; Batistote, M.; Cavalheiro, A.A.;
Neves, A.; Rodrigues, D.C.; Dos Anjos, A. Study of the antimicrobial activity of metal complexes and their
ligands through bioassays applied to plant extracts. Rev. Bras. Farm. 2014, 24, 309–315. [CrossRef]
35. Kopel, P.; Cermakova, S.; Dolezal, K.; Kalinska, B.; Bienko, A.; Mrozinski, J. Synthesis and properties of a
trinuclear copper(II) complex with trithiocyanurate bridge. Pol. J. Chem. 2007, 81, 327–335.
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